|
If your body starts fighting you, PDL BioPharma hopes to help you fight back. The company's antibody (protein) humanization technology makes it possible to alter mouse monoclonal antibodies (MAbs) for improved use in therapies for humans, such as preventing and treating autoimmune diseases and cancer. The firm has licensed its technology to such companies as MedImmune and Genentech for therapies including Genentech's best-selling breast-cancer treatment MAb Herceptin. The company has spun off its biotech development operations into a new company named Facet Biotech to separate them from its profit-making licensing and royalty business.
|
| | | Contact Information | |
Address: |
932 Southwood Blvd.
Incline Village, NV 89451
| | Phone: | 775-832-8500 | | Fax: | 775-832-8501 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 294.30 M | | Revenue Growth (1 yr): | 13.70% | | Employees (2008): | 6 | | Employee Growth (1 yr): | (-99.30%) |
|
|
Key People
| | • |
President, CEO, and Director:
John P. McLaughlin
| | • |
VP and CFO:
Christine R. (Cris) Larson
|
|
|
